Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 25 (1) , 57-71
- https://doi.org/10.2165/00002018-200225010-00005
Abstract
Inhaled corticosteroids have a proven benefit in the management of asthma, but until recently, their efficacy in non-asthmatic, smoking-related chronic obstructive pulmonary disease (COPD) was not...Keywords
This publication has 70 references indexed in Scilit:
- Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysisThorax, 1999
- Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary diseaseThorax, 1998
- Airways responsiveness and development and remission of chronic respiratory symptoms in adultsThe Lancet, 1997
- Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitisEuropean Respiratory Journal, 1994
- Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.Thorax, 1993
- Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.Thorax, 1992
- Acute adrenal insufficiency associated with high dose inhaled steroids.BMJ, 1992
- Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.Thorax, 1991
- Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.Thorax, 1990
- The immunological component of the cellular inflammatory infiltrate in bronchiectasis.Thorax, 1989